Prevalence, Risk Factors, and Genetic Traits in Metabolically Healthy and Unhealthy Obese Individuals

BioMed Research International

Volumn 2015, Issue , 2015, Pages

  Berezina, A ^a   Belyaeva, O ^a,b   Berkovich, O ^b   Baranova, E ^b   Karonova, T ^a   Bazhenova, E ^b   Brovin, D ^b   Grineva, E ^a   Shlyakhto, E ^a,b  

^a ALMAZOV NATIONAL MEDICAL RESEARCH CENTRE   (Russian Federation)

^b PAVLOV FIRST SAINT PETERSBURG STATE MEDICAL UNIVERSITY   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; GENOMIC DNA; GLUCOSE; INSULIN; LEPTIN; LIPID; ADIPOQ PROTEIN, HUMAN; GLUCOSE BLOOD LEVEL; LEPTIN RECEPTOR; LEPTIN RECEPTOR, HUMAN;

ABDOMINAL OBESITY; ADULT; ANTHROPOMETRIC PARAMETERS; ARTICLE; BLOOD PRESSURE; CONCENTRATION (PARAMETERS); DNA EXTRACTION; DNA POLYMORPHISM; FEMALE; GENETIC TRAIT; GENOTYPE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PHYSICAL ACTIVITY; PREVALENCE; RECEPTOR GENE; RISK ASSESSMENT; RISK FACTOR; WAIST CIRCUMFERENCE; BLOOD; BODY MASS; GENETICS; METABOLISM; MIDDLE AGED; OBESITY, ABDOMINAL; OBESITY, METABOLICALLY BENIGN; RUSSIAN FEDERATION; SINGLE NUCLEOTIDE POLYMORPHISM;

ADIPONECTIN; ADULT; BLOOD GLUCOSE; BLOOD PRESSURE; BODY MASS INDEX; FEMALE; HUMANS; INSULIN; LEPTIN; LIPIDS; MALE; MIDDLE AGED; OBESITY, ABDOMINAL; OBESITY, METABOLICALLY BENIGN; POLYMORPHISM, SINGLE NUCLEOTIDE; PREVALENCE; RECEPTORS, LEPTIN; RISK FACTORS; RUSSIA; WAIST CIRCUMFERENCE;

EID: 84945316867     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2015/548734     Document Type: Article

References (63)

1. J.-P. Després, "Abdominal obesity: the most prevalent cause of the metabolic syndrome and related cardiometabolic risk," European Heart Journal, Supplement, vol. 8, pp. B4-B12, 2006.
2. C. J. Girman, T. Rhodes,M.Mercuri et al., "The metabolic syndrome and risk of major coronary events in the Scandinavian Simvastatin Survival Study (4S) and the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS)," The American Journal of Cardiology, vol. 93, no. 2, pp. 136-141, 2004.
3. H.-M. Lakka,D. E. Laaksonen, T.A. Lakka et al., "Themetabolic syndrome and total and cardiovascular disease mortality in middle-aged men,"The Journal of the American Medical Association, vol. 288, no. 21, pp. 2709-2716, 2002.
4. J. B. Meigs, P. W. F. Wilson, C. S. Fox et al., "Bodymass index, metabolic syndrome, and risk of type 2 diabetes or cardiovascular disease," Journal of Clinical Endocrinology and Metabolism, vol. 91, no. 8, pp. 2906-2912, 2006.
5. E. Bonora, S. Kiechl, J. Willeit et al., "Prevalence of insulin resistance in metabolic disorders: the Bruneck Study," Diabetes, vol. 47, no. 10, pp. 1643-1649, 1998.
6. M. Brochu,A. Tchernof, I. J. Dionne et al., "What are the physical characteristics associated with a normal metabolic profile despite a high level of obesity in postmenopausal women?" The Journal of Clinical Endocrinology & Metabolism, vol. 86, no. 3, pp. 1020-1025, 2001.
7. A. D. Karelis, M. Faraj, J.-P. Bastard et al., "The metabolically healthy but obese individual presents a favorable inflammation profile," The Journal of Clinical Endocrinology and Metabolism, vol. 90, no. 7, pp. 4145-4150, 2005.
8. J. L. Kuk and C. I. Ardern, "Aremetabolically normal but obese individuals at lower risk for all-cause mortality?" Diabetes Care, vol. 32, no. 12, pp. 2297-2299, 2009.
9. R. P. Wildman, P. Muntner, K. Reynolds et al., "The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: prevalence and correlates of 2 phenotypes among the US population (NHANES 1999-2004)," Archives of Internal Medicine, vol. 168, no. 15, pp. 1617-1624, 2008.
10. E. Ferrannini, A. Natali, P. Bell, P. Cavallo-Perin, N. Lalic, and G. Mingrone, "Insulin resistance and hypersecretion in obesity. European Group for the Study of Insulin Resistance (EGIR)," The Journal of Clinical Investigation, vol. 100, no. 5, pp. 1166-1173, 1997.
11. C. A.Aguilar-Salinas, E. G. García, L. Robles et al., "Highadiponectin concentrations are associated with the metabolically healthy obese phenotype," Journal of Clinical Endocrinology and Metabolism, vol. 93, no. 10, pp. 4075-4079, 2008.
12. G. Iacobellis, M. C. Ribaudo, A. Zappaterreno, C. V. Iannucci, and F. Leonetti, "Prevalence of uncomplicated obesity in an Italian obese population," Obesity Research, vol. 13, no. 6, pp. 1116-1122, 2005.
13. V. Messier, A. D. Karelis, D. Prud'Homme, V. Primeau, M. Brochu, and R. Rabasa-Lhoret, "Identifying metabolically healthy but obese individuals in sedentary postmenopausal women," Obesity, vol. 18, no. 5, pp. 911-917, 2010.
14. D. R. Matthews, J. P. Hosker, A. S. Rudenski, B. A. Naylor, D. F. Treacher, and R. C. Turner, "Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man," Diabetologia, vol. 28, no. 7, pp. 412-419, 1985.
15. N. Blin and D. W. Stafford, "A general method for isolation of high molecular weight DNA from eukaryotes," Nucleic Acids Research, vol. 3, no. 9, pp. 2303-2308, 1976.
16. R. Lucantoni, E. Ponti,M. E. Berselli et al., "The A19G polymorphism in the 5 untranslated region of the human obese gene does not affect leptin levels in severely obese patients," Journal of Clinical Endocrinology andMetabolism, vol. 85,no. 10,pp. 3589-3591, 2000.
17. T.Gotoda, B. S.Manning, A. P.Goldstone et al., "Leptin receptor gene variation and obesity: lack of association in a white British male population," Human Molecular Genetics, vol. 6, no. 6, pp. 869-876, 1997.
18. J. Křížová, M. Dolinková, Z. Lacinová et al., "Adiponectin and resistin gene polymorphisms in patients with anorexia nervosa and obesity and its influence on metabolic phenotype," Physiological Research, vol. 57, no. 4, pp. 539-546, 2008.
19. N. Xita, I. Georgiou, A. Chatzikyriakidou et al., "Effect of adiponectin gene polymorphisms on circulating adiponectin and insulin resistance indexes in women with polycystic ovary syndrome," Clinical Chemistry, vol. 51, no. 2, pp. 416-423, 2005.
20. C. L. Jennings, E. V. Lambert, M. Collins, Y. Joffe, N. S. Levitt, and J. H. Goedecke, "Determinants of insulin-resistant phenotypes in normal-weight and obese black african women," Obesity, vol. 16, no. 7, pp. 1602-1609, 2008.
21. E. Muscelli, S. Camastra, A. Gastaldelli et al., "Influence of duration of obesity on the insulin resistance of obese nondiabetic patients," International Journal of Obesity, vol. 22, no. 3, pp. 262-267, 1998.
22. N. Stefan, K. Kantartzis, J. Machann et al., "Identification and characterization of metabolically benign obesity in humans," Archives of Internal Medicine, vol. 168, no. 15, pp. 1609-1616, 2008.
23. A. Berezina, E. Baranova, O. Belyaeva, and O. Berkovich, "Physical capacity and changings of lipid profile and CRP level in patients with abdominal obesity," in Proceedings of the 2nd Latin America Congress on Controversies to Consensus in Diabetes, Obesity and Hypertension, p. 9A, Rio de Janeiro, Brazil, March 2012.
24. M. K. Karvonen, U. Pesonen, P. Heinonen et al., "Identification of new sequence variants in the leptin gene," Journal of Clinical Endocrinology and Metabolism, vol. 83, no. 9, pp. 3239-3242, 1998.
25. J. Hager, K. Clement, S. Francke et al., "A polymorphism in the 5 untranslated region of the human ob gene is associated with low leptin levels," International Journal of Obesity, vol. 22, no. 3, pp. 200-205, 1998.
26. W.-D. Li, D. R. Reed, J.H. Lee et al., "Sequence variants in the 5 flanking region of the leptin gene are associated with obesity in women," Annals of Human Genetics, vol. 63, no. 3, pp. 227-234, 1999.
27. V. S. Mattevi, V. M. Zembrzuski, and M. H. Hutz, "Association analysis of genes involved in the leptin-signaling pathway with obesity in Brazil," International Journal of Obesity, vol. 26, no. 9, pp. 1179-1185, 2002.
28. S. Francke, K. Clement, C. Dina et al., "Genetic studies of the leptin receptor gene in morbidly obese French Caucasian families," Human Genetics, vol. 100, no. 5-6, pp. 491-496, 1997.
29. W. K. Chung, L. Power-Kehoe, M. Chua et al., "Exonic and intronic sequence variation in the human leptin receptor gene (LEPR)," Diabetes, vol. 46, no. 9, pp. 1509-1511, 1997.
30. D. B. Thompson, E. Ravussin, P. H. Bennett, and C. Bogardus, "Structure and sequence variation at the human leptin receptor gene in lean and obese Pima Indians," Human Molecular Genetics, vol. 6, no. 5, pp. 675-679, 1997.
31. E. E. Calle, M. J. Thun, J. M. Petrelli, C. Rodriguez, and C. W. Heath Jr., "Body-mass index and mortality in a prospective cohort ofU.S.Adults,"TheNewEngland Journal ofMedicine, vol. 341, no. 15, pp. 1097-1105, 1999.
32. N. Yiannakouris, M. Yannakoulia, L. Melistas, J. L. Chan, D. Klimis-Zacas, and C. S.Mantzoros, "TheQ223R polymorphism of the leptin receptor gene is significantly associated with obesity and predicts a small percentage of bodyweight and body composition variability," Journal of Clinical Endocrinology and Metabolism, vol. 86, no. 9, pp. 4434-4439, 2001.
33. C. C. Ragin, C.Dallal,M.Okobia et al., "Leptin levels and leptin receptor polymorphism frequency in healthy populations," Infectious Agents and Cancer, vol. 4, supplement 1, article S13, 2009.
34. N.Matsuoka, Y. Ogawa, K. Hosoda et al., "Human leptin receptor gene in obese Japanese subjects: evidence against either obesity-causing mutations or association of sequence variants with obesity," Diabetologia, vol. 40, no. 10, pp. 1204-1210, 1997.
35. S. M. Echwald, S. B. Rasmussen, T. I. A. Sorensen et al., "Identification of two novel missense mutations in the human OB gene," International Journal of Obesity, vol. 21, no. 4, pp. 321-326, 1997.
36. N. D. Quinton, A. J. Lee, R. J. M. Ross, R. Eastell, and A. I. F. Blakemore, "A single nucleotide polymorphism (SNP) in the leptin receptor is associated with BMI, fatmass and leptin levels in postmenopausal Caucasian women," Human Genetics, vol. 108, no. 3, pp. 233-236, 2001.
37. C. T. M. van Rossum, B. Hoebee, J. C. Seidell et al., "Genetic factors as predictors of weight gain in young adult Dutch men and women," International Journal of Obesity, vol. 26, no. 4, pp. 517-528, 2002.
38. Y. C. Chagnon, J. H.Wilmore, I. B. Borecki et al., "Associations between the leptin receptor gene and adiposity in middle-aged Caucasian males from the HERITAGE family Study," Journal of Clinical Endocrinology andMetabolism, vol. 85, no. 1, pp. 29-34, 2000.
39. V. Paracchini, P. Pedotti, and E. Taioli, "Genetics of leptin and obesity: aHuGE review," American Journal of Epidemiology, vol. 162, no. 2, pp. 101-114, 2005.
40. K. Clément, "Leptin and the genetics of obesity," Acta Paediatrica, vol. 88, no. 428, pp. 51-57, 1999.
41. M. Wauters, I. Mertens, T. Rankinen, M. Chagnon, C. Bouchardt, and L. Van Gaal, "Leptin receptor gene polymorphisms are associated with insulin in obese women with impaired glucose tolerance," Journal of Clinical Endocrinology and Metabolism, vol. 86, no. 7, pp. 3227-3232, 2001.
42. M. G. V. Gottlieb, L. C. Bodanese, L. E. A. Leite et al., "Association between the Gln223Arg polymorphism of the leptin receptor and metabolic syndrome in free-living community elderly," Metabolic Syndrome and Related Disorders, vol. 7, no. 4, pp. 341-348, 2009.
43. O. Belyaeva, E. Bazhenova, T. Karonova et al., "Leptin levels and Q223R leptin receptor gene polymorphism in patients with abdominal obesity," in Proceedings of the Latin America Symposium on Controversies to Consensus in Diabetes, Obesity and Hypertension, 550, Buenos Aires, Argentina, 2010.
44. G. M. van der Vleuten, L. A. Kluijtmans, A. Hijmans, H. J. Blom, A. F. H. Stalenhoef, and J. De Graaf, "The Gln223Arg polymorphism in the leptin receptor is associated with familial combined hyperlipidemia," International Journal of Obesity, vol. 30, no. 6, pp. 892-898, 2006.
45. J. Zacharova, J.-L. Chiasson, and M. Laakso, "The common polymorphisms (single nucleotide polymorphism [SNP] + 45 and SNP + 276) of the adiponectin gene predict the conversion from impaired glucose tolerance to type 2 diabetes: the STOPNIDDM trial," Diabetes, vol. 54, no. 3, pp. 893-899, 2005.
46. N. F. Butte, A. G. Comuzzie, G. Cai, S. A. Cole,N. R.Mehta, and C. A. Bacino, "Genetic and environmental factors influencing fasting serum adiponectin in hispanic children," The Journal of Clinical Endocrinology & Metabolism, vol. 90, no. 7, pp. 4170-4176, 2005.
47. M. Stumvoll, O. Tschritter, A. Fritsche et al., "Association of the T-G polymorphism in adiponectin (exon 2) with obesity and insulin sensitivity: interaction with family history of type 2 diabetes," Diabetes, vol. 51, no. 1, pp. 37-41, 2002.
48. K. Hara, P. Boutin, Y.Mori et al., "Genetic variation in the gene encoding adiponectin is associated with an increased risk of type 2 diabetes in the Japanese population," Diabetes, vol. 51, no. 2, pp. 536-540, 2002.
49. H. Kondo, L. Shimomura, Y. Matsukawa et al., "Association of adiponectin mutation with type 2 diabetes: a candidate gene for the insulin resistance syndrome," Diabetes, vol. 51, no. 7, pp. 2325-2328, 2002.
50. W.-S. Yang, C. A. Hsiung, L.-T. Ho et al., "Genetic epistasis of adiponectin and PPARγ2 genotypes in modulation of insulin sensitivity: a family-based association study," Diabetologia, vol. 46, no. 7, pp. 977-983, 2003.
51. W.-S. Yang and L.-M. Chuang, "Human genetics of adiponectin in the metabolic syndrome," Journal ofMolecularMedicine, vol. 84, no. 2, pp. 112-121, 2006.
52. D. R. Gable, S. J. Hurel, and S. E. Humphries, "Adiponectin and its gene variants as risk factors for insulin resistance, the metabolic syndrome and cardiovascular disease," Atherosclerosis, vol. 188, no. 2, pp. 231-244, 2006.
53. C. Menzaghi, T. Ercolino, R. D. Paola et al., "A haplotype at the adiponectin locus is associated with obesity and other features of the insulin resistance syndrome," Diabetes, vol. 51, no. 7, pp. 2306-2312, 2002.
54. C. Menzaghi, V. Trischitta, and A. Doria, "Genetic influences of adiponectin on insulin resistance, type 2 diabetes, and cardiovascular disease," Diabetes, vol. 56, no. 5, pp. 1198-1209, 2007.
55. W.-S. Yang, Y.-C. Yang, C.-L. Chen et al., "Adiponectin SNP276 is associated with obesity, themetabolic syndrome, and diabetes in the elderly," The American Journal of Clinical Nutrition, vol. 86, no. 2, pp. 509-513, 2007.
56. F. Vasseur, N. Helbecque, C. Dina et al., "Single-nucleotide polymorphism haplotypes in the both proximal promoter and exon 3 of the APM1 gene modulate adipocyte-secreted adiponectin hormone levels and contribute to the genetic risk for type 2 diabetes in French Caucasians," Human Molecular Genetics, vol. 11, no. 21, pp. 2607-2614, 2002.
57. O. Ukkola, E. Ravussin, P. Jacobson, L. Sjöström, and C. Bouchard, "Mutations in the adiponectingene in leanandobese subjects from the Swedish obese subjects cohort," Metabolism, vol. 52, no. 7, pp. 881-884, 2003.
58. M.-T. Berthier, A.Houde, M. Côté et al., "Impact of adiponectin gene polymorphisms on plasma lipoprotein and adiponectin concentrations of viscerally obese men," Journal of Lipid Research, vol. 46, no. 2, pp. 237-244, 2005.
59. J. L. González-Sánchez, C. A. Zabena, M. T. Martínez-Larrad et al., "An SNP in the adiponectin gene is associated with decreased serum adiponectin levels and risk for impaired glucose tolerance," Obesity Research, vol. 13, no. 5, pp. 807-812, 2005.
60. M. Stumvoll, O. Tschritter, A. Fritsche et al., "Association of the T-G polymorphism in adiponectin (Exon 2) with obesity and insulin sensitivity: interaction with family history of type 2 diabetes," Diabetes, vol. 51, no. 1, pp. 37-41, 2002.
61. U. Salmenniemi, J. Zacharova, E. Ruotsalainen et al., "Association of adiponectin level and variants in the adiponectin gene with glucose metabolism, energy expenditure, and cytokines in offspring of type 2 diabetic patients," Journal of Clinical Endocrinology and Metabolism, vol. 90, no. 7, pp. 4216-4223, 2005.
62. F. Fumeron, R. Aubert, A. Siddiq et al., "Adiponectin gene polymorphisms and adiponectin levels are independently associated with the development of hyperglycemia during a 3-year period: the epidemiologic data on the insulin resistance syndrome prospective study," Diabetes, vol. 53, no. 4, pp. 1150-1157, 2004.
63. F. Mousavinasab, T. Tähtinen, J. Jokelainen et al., "Common polymorphisms (single-nucleotide polymorphisms SNP+45 and SNP+276) of the adiponectin gene regulate serum adiponectin concentrations and blood pressure in young Finnish men,"Molecular Genetics andMetabolism, vol. 87,no. 2, pp. 147-151, 2006.